BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16731366)

  • 1. MR spectroscopy and spectroscopic imaging: comparing 3.0 T versus 1.5 T.
    Dydak U; Schär M
    Neuroimaging Clin N Am; 2006 May; 16(2):269-83, x. PubMed ID: 16731366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Slice-selective FID acquisition, localized by outer volume suppression (FIDLOVS) for (1)H-MRSI of the human brain at 7 T with minimal signal loss.
    Henning A; Fuchs A; Murdoch JB; Boesiger P
    NMR Biomed; 2009 Aug; 22(7):683-96. PubMed ID: 19259944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3.0-T functional brain imaging: a 5-year experience.
    Scarabino T; Giannatempo GM; Popolizio T; Tosetti M; d'Alesio V; Esposito F; Di Salle F; Di Costanzo A; Bertolino A; Maggialetti A; Salvolini U
    Radiol Med; 2007 Feb; 112(1):97-112. PubMed ID: 17310287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3.0 T neuroimaging: technical considerations and clinical applications.
    Willinek WA; Kuhl CK
    Neuroimaging Clin N Am; 2006 May; 16(2):217-28, ix. PubMed ID: 16731361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3 Tesla magnetic resonance imaging of the brain. Better morphological and functional images with higher magnetic field strength].
    Larsson EM; Ståhlberg F
    Lakartidningen; 2005 Feb 14-20; 102(7):460-3. PubMed ID: 15768694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T.
    Li Y; Osorio JA; Ozturk-Isik E; Chen AP; Xu D; Crane JC; Cha S; Chang S; Berger MS; Vigneron DB; Nelson SJ
    Magn Reson Imaging; 2006 Dec; 24(10):1295-302. PubMed ID: 17145400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives and limitations of parallel MR imaging at high field strengths.
    Heidemann RM; Seiberlich N; Griswold MA; Wohlfarth K; Krueger G; Jakob PM
    Neuroimaging Clin N Am; 2006 May; 16(2):311-20, xi. PubMed ID: 16731369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantitation of glutamate in the brain by using MR proton spectroscopy at 1.5 T and 3 T].
    Gussew A; Rzanny R; Scholle HC; Kaiser WA; Reichenbach JR
    Rofo; 2008 Aug; 180(8):722-32. PubMed ID: 18512190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke imaging at 3.0 T.
    Lauzon ML; Sevick RJ; Demchuk AM; Frayne R
    Neuroimaging Clin N Am; 2006 May; 16(2):343-66, xii. PubMed ID: 16731371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of diffusion tensor imaging measurements at 3.0 T versus 1.5 T with and without parallel imaging.
    Alexander AL; Lee JE; Wu YC; Field AS
    Neuroimaging Clin N Am; 2006 May; 16(2):299-309, xi. PubMed ID: 16731368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update of prostate magnetic resonance imaging at 3 T.
    Kim CK; Park BK
    J Comput Assist Tomogr; 2008; 32(2):163-72. PubMed ID: 18379296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen MR imaging of the head at 0.35 T and 0.7 T: effects of magnetic field strength.
    Posin JP; Arakawa M; Crooks LE; Feinberg DA; Hoenninger JC; Watts JC; Mills CM; Kaufman L
    Radiology; 1985 Dec; 157(3):679-83. PubMed ID: 4059555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast 3D echo planar SSFP-based 1H spectroscopic imaging: demonstration on the rat brain in vivo.
    Althaus M; Dreher W; Geppert C; Leibfritz D
    Magn Reson Imaging; 2006 Jun; 24(5):549-55. PubMed ID: 16735175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3.0 T magnetic resonance in neuroradiology.
    Scarabino T; Nemore F; Giannatempo GM; Bertolino A; Di Salle F; Salvolini U
    Eur J Radiol; 2003 Nov; 48(2):154-64. PubMed ID: 14680906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3.0 T versus 1.5 T MR angiography of the head and neck.
    DeLano MC; DeMarco JK
    Neuroimaging Clin N Am; 2006 May; 16(2):321-41, xi. PubMed ID: 16731370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on body MR imaging at ultrahigh field.
    Hecht EM; Lee RF; Taouli B; Sodickson DK
    Magn Reson Imaging Clin N Am; 2007 Aug; 15(3):449-65, viii. PubMed ID: 17893062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective maximization of (31)P MR spectroscopic signals of in vivo human brain metabolites at 3T.
    Blenman RA; Port JD; Felmlee JP
    J Magn Reson Imaging; 2007 Mar; 25(3):628-34. PubMed ID: 17279535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of 3-T magnetic resonance imaging in local staging of prostate cancer.
    Fütterer JJ; Barentsz JO; Heijmink SW
    Top Magn Reson Imaging; 2008 Dec; 19(6):285-9. PubMed ID: 19512850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technical challenges and opportunities of whole-body magnetic resonance imaging at 3T.
    Machann J; Schlemmer HP; Schick F
    Phys Med; 2008 Jun; 24(2):63-70. PubMed ID: 18308606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution 3D MR spectroscopic imaging of the prostate at 3 T with the MLEV-PRESS sequence.
    Chen AP; Cunningham CH; Kurhanewicz J; Xu D; Hurd RE; Pauly JM; Carvajal L; Karpodinis K; Vigneron DB
    Magn Reson Imaging; 2006 Sep; 24(7):825-32. PubMed ID: 16916699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.